Table 1.
Mean (SD) of AIPE scores of all patients (n = 100)
| Baseline | Active drug | ||
|---|---|---|---|
| Group 1 | Q1 | 3.9 ± 0.3 | 4 ± 0.3 |
| n = 33 | Q2 | 4.4 ± 0.4 | 4.4 ± 0.1 |
| Q3 | 2.7 ± 0.2 | 3.6 ± 0.4* | |
| Q4 | 1.5 ± 0.2 | 2.2 ± 0.3* | |
| Q5 | 2.6 ± 0.6 | 3.4 ± 0.5* | |
| Q6 | 2 ± 0.5 | 2.4 ± 0.3 | |
| Q7 | 3 ± 0.7 | 3.7 ± 0.2* | |
| Total score | 20.3 ± 2.3 | 24 ± 2.3* | |
| Group 2 | |||
| Q1 | 4.3 ± 0.3 | 4.2 ± 0.2 | |
| n = 37 | Q2 | 4.4 ± 0.1 | 4.5 ± 0.1 |
| Q3 | 2.5 ± 0.3 | 3.7 ± 0.5* | |
| Q4 | 1.3 ± 0.4 | 2.2 ± 0.2* | |
| Q5 | 2.4 ± 0.3 | 3.1 ± 0.7* | |
| Q6 | 2 ± 0.6 | 2.3 ± 0.3 | |
| Q7 | 3.3 ± 0.3 | 4 ± 0.4* | |
| Total score | 20.3 ± 3.3 | 24.2 ± 2.3* | |
| Group 3 | |||
| n = 33 | Q1 | 4.2 ± 0.3 | 4.3 ± 0.7 |
| Q2 | 4.2 ± 0.5 | 4.2 ± 0.5 | |
| Q3 | 2.2 ± 0.3 | 3.2 ± 0.6* | |
| Q4 | 1.4 ± 0.6 | 2.2 ± 0.2* | |
| Q5 | 2.7 ± 0.3 | 3.1 ± 0.7* | |
| Q6 | 2.3 ± 0.2 | 2.6 ± 0.6 | |
| Q7 | 2.9 ± 0.5 | 3.8 ± 0.6* | |
| Total score | 19.7 ± 3.1 | 23.6 ± 2.3* | |
*
Note: p < 0.05 vs baseline.